Subjects: Drug and Narcotic Control / Dates by Range: 2000 and later - Digital Collections - National Library of Medicine Search Results

Start Over Subjects Drug and Narcotic Control ✖ Dates by Range 2000 and later ✖

11. Illicit opioids: while greater attention given to combating synthetic opioids, agencies need to better assess their efforts : report to Congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, March 2018
Subject(s):: Analgesics, Opioid
Drug and Narcotic Control
Drug Trafficking -- prevention & control
Illicit Drugs
United States

12. Illegal marijuana: opportunities exist to improve oversight of state and local eradication efforts : report to Congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, November 2018
Subject(s):: Cannabis
Drug and Narcotic Control
Local Government
State Government
United States
United States. Drug Enforcement Administration.

13. Buprenorphine: an overview for clinicians

Author(s):: Steiger, Scott, author
DeFries, Triveni, author
Publication:: [Oakland, California] : California Health Care Foundation, August 2019
Subject(s):: Buprenorphine -- therapeutic use
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Ambulatory Care
Buprenorphine -- administration & dosage
Buprenorphine -- adverse effects
Drug and Narcotic Control
Emergency Service, Hospital
Health Services Accessibility
Mental Health Services
Methadone -- therapeutic use
Naltrexone -- therapeutic use
Pain -- drug therapy
Prescription Drug Diversion
Prisons
State Government
Telemedicine
Humans
California
United States

14. Definitions of suspect product and illegitimate product for verification obligations under the Drug Supply Chain Security Act: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, March 2023
Subject(s):: Drug Industry
Legislation, Drug
Drug Packaging
Drug and Narcotic Control
Government Regulation
United States

15. Enhanced drug distribution security at the package level under the Drug Supply Chain Security Act: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, August 2023
Subject(s):: Drug Industry
Drug and Narcotic Control
Drug Packaging
Government Regulation
Security Measures
United States
United States.
United States.

16. Considerations for the use of real-world data and real-world evidence to support regulatory decision-making for drug and biological products: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, August 2023
Subject(s):: Biological Products
Clinical Trials as Topic
Data Analysis
Decision Making
Drug Approval
Drug Industry
Drug and Narcotic Control
Government Regulation
United States
United States.

17. Wholesale distributor verification requirement for saleable returned drug product and dispenser verification requirements when investigating a suspect or illegitimate product: compliance policies : guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, August 2023
Subject(s):: Counterfeit Drugs
Drug Industry
Drug and Narcotic Control
Fraud
Government Regulation
Substandard Drugs
United States
United States.